FourThought Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Buy
32,203
+231
+0.7% +$82.3K 0.98% 33
2025
Q4
$10.5M Buy
31,972
+349
+1% +$111K 0.88% 33
2025
Q3
$8.92M Buy
31,623
+132
+0.4% +$38.3K 0.78% 39
2025
Q2
$8.79M Sell
31,491
-4
-0% -$1.13K 0.87% 37
2025
Q1
$9.81M Buy
31,495
+477
+2% +$141K 1.03% 30
2024
Q4
$8.08M Buy
31,018
+239
+0.8% +$70.9K 0.84% 36
2024
Q3
$9.92M Sell
30,779
-94
-0.3% -$30.7K 1.18% 25
2024
Q2
$9.65M Sell
30,873
-128
-0.4% -$37.6K 1.24% 25
2024
Q1
$8.81M Sell
31,001
-792
-2% -$232K 1.01% 29
2023
Q4
$9.16M Sell
31,793
-1,081
-3% -$295K 1.15% 26
2023
Q3
$8.84M Sell
32,874
-2,907
-8% -$725K 1.23% 25
2023
Q2
$7.94M Buy
35,781
+766
+2% +$178K 1.04% 31
2023
Q1
$8.47M Sell
35,015
-553
-2% -$136K 1.16% 26
2022
Q4
$9.34M Buy
+35,568
New +$9.53M 1.35% 21

Other funds holding AMGN

FourThought Financial Partners's AMGN Position: Q1 2026 in Review

FourThought Financial Partners increased its Amgen (AMGN) stake by 0.72% in Q1 2026, buying an estimated $82.3K and bringing the position to 32,203 shares worth $11.3M. The position accounts for 0.98% of the portfolio, ranked #33.

FourThought Financial Partners first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • FourThought Financial Partners held 32,203 shares of Amgen worth $11.3M as of Q1 2026.
  • FourThought Financial Partners bought 231 Amgen shares in Q1 2026, an estimated $82.3K.
  • Amgen made up 0.98% of FourThought Financial Partners's portfolio in Q1 2026, its #33 holding.
  • FourThought Financial Partners first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.